Transnational Cannabis Ltd
OTC:TRCNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Transnational Cannabis Ltd
Cash Equivalents
Transnational Cannabis Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Transnational Cannabis Ltd
OTC:TRCNF
|
Cash Equivalents
CA$1.1m
|
CAGR 3-Years
373%
|
CAGR 5-Years
104%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash Equivalents
$1.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash Equivalents
CA$169m
|
CAGR 3-Years
32%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
24%
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash Equivalents
$791.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
99%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Cash Equivalents
CA$5.4m
|
CAGR 3-Years
161%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-32%
|
|
Transnational Cannabis Ltd
Glance View
Transnational Cannabis Ltd. is a biotechnology company that engages in the development and production of medical marijuana. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-08. The firm is engaged in the cultivation, extraction, formulation and distribution of cannabis internationally.
See Also
What is Transnational Cannabis Ltd's Cash Equivalents?
Cash Equivalents
1.1m
CAD
Based on the financial report for Feb 28, 2019, Transnational Cannabis Ltd's Cash Equivalents amounts to 1.1m CAD.
What is Transnational Cannabis Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
104%
Over the last year, the Cash Equivalents growth was 1 414%. The average annual Cash Equivalents growth rates for Transnational Cannabis Ltd have been 373% over the past three years , 104% over the past five years .
